Cancer and cardiac diseases are the most prevalent causes of death in most developed
countries. Due to the earlier detection and higher effectiveness of treatment, more patients …

This study aimed to conduct a methodological review of drug-related toxicological studies in
Saudi Arabia. A systematic review and a methodological analysis were conducted according …

Trastuzumab (TZM) is a humanized monoclonal antibody that has been approved for the
clinical management of HER2‐positive metastatic breast and gastric cancers but its use is …

Abstract Aims In contrast to Western patients with breast cancer, Asian patients are relatively
younger at diagnosis, and most are free from traditional cardiovascular risk factors. Despite …

Background Drug-induced cardiotoxicity (DICT) is one of the most serious adverse drug
reactions, which is an important safety issue in drug development and clinical practice. This …

The effect of BMI as a risk factor in trastuzumab-induced cardiotoxicity in Saudi patients with
HER2‑neu positive breast cancer treated with trastuzumab and anthracyclines is not fully …

Introduction Breast cancer patients undergoing trastuzumab therapy have greater risk of
cardiovascular disease. Risk factors for this effect have been proposed. However, the role of …

Sažetak Karcinom dojke je najčešći karcinom kod žena. Veliki napredak u otkrivanju i
liječenju karcinoma dojke poboljšao je prognozu bolesti i povećao preživljenje oboljelih …

Aim: In this study, we aimed to investigate the incidence rate, risk factors, and mortality rates
in patients with early-stage breast cancer using anti-HER2 (Human epidermal growth factor …

Background: Breast cancer (BC) is one of the most common cancers among women. The
survival of the BC patients is based on new treatment protocols. Cardiotoxicity is the most …